Rangeley Capital »

Corbus Pharmaceuticals Hldgs shares owned by Rangeley Capital

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $421k 45k 9.39

More positions owned by Rangeley Capital

Liquidia Corporation Com New Put Option (LQDA)
Driven Brands Hldgs (DRVN)
Revolution Medicines (RVMD)
Prothena Corp SHS (PRTA)
Seaport Entmt Group Common Stock (SEG)
Warner Bros Discovery Com Ser A (WBD)
Grindr (GRND)
Delek Us Holdings (DK)
Arvinas Ord (ARVN)
Arbutus Biopharma (ABUS)
Echostar Corp Cl A (SATS)
Leggett & Platt (LEG)
Star Hldgs Shs Ben Int (STHO)
Full House Resorts (FLL)
Tripadvisor (TRIP)

View all positions for Rangeley Capital

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
OrbiMed Advisors
Standard Life Aberdeen
Vanguard Group
Citadel Advisors
Vanguard Capital Management
Prosight Management
Stonepine Capital Management
ADAR1 Capital Management
Armistice Capital
Renaissance Technologies
BlackRock
Susquehanna International
Brian McDonald
Geode Capital Management

View all funds holding Corbus Pharmaceuticals Hldgs